$ACT Company News AstraZeneca to buy Actavis r
Post# of 94146
Posted On: 02/15/2015 12:14:09 PM
$ACT Company News
AstraZeneca to buy Actavis respiratory-drug unit 3:20 a.m. Feb. 5, 2015 - MarketWatch.com
Allergan profit surges on higher sales 5:50 p.m. Feb. 4, 2015 - MarketWatch.com
Options remain limited for growth-stock speculators 3:16 p.m. Jan. 22, 2015 - The Trading Deck
These unloved stocks may beat the S&P 500 again in 2015 10:56 a.m. Jan. 20, 2015 - Brett Arends
10 hated stocks your portfolio will love 6:01 a.m. Jan. 20, 2015 - Brett Arends
Actavis expects profit to beat expectations 9:44 a.m. Jan. 12, 2015 - Michael Calia
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
10 stocks that can withstand a rocky 2015 12:31 p.m. Dec. 31, 2014 - The Trading Deck
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Here are the best S&P 500 stocks and sectors of 2014 1:52 p.m. Dec. 29, 2014 - Philip van Doorn
2014 was the year that all predictions were wrong 11:29 a.m. Dec. 26, 2014 - Marek Fuchs
GoPro, Adamas climb, Cal-Maine slides 10:06 a.m. Dec. 24, 2014 - MarketWatch
Adamas' stock soars after dementia treatment approval 8:24 a.m. Dec. 24, 2014 - Tomi Kilgore
Second 2% S&P 500 spike signals strong bull trend 11:23 a.m. Dec. 19, 2014 - Michael Ashbaugh
What a week: Botox haze, merger Monday and The Tanned One 9:19 a.m. Nov. 21, 2014 - Marek Fuchs
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Nov. 20, 2014 - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
S&P, Dow ring up records Tuesday 4:35 p.m. Nov. 18, 2014 - Barbara Kollmeyer
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Jim Cramer's Top Stock Picks: ACT PCLN CLX HAIN WWAV NVAX 6:00 a.m. Feb. 14, 2015 - TheStreet.com
How Alger’s Patrick Kelly Stays Ahead of the Game 2:15 a.m. Feb. 14, 2015 - Barrons.com
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:03 p.m. Feb. 13, 2015 - TheStreet.com
Salix, Top Drug Stocks Rally As Merger Mania Heats Up 5:08 p.m. Feb. 13, 2015 - Investors Business Daily
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More 4:00 p.m. Feb. 13, 2015 - Seeking Alpha
AstraZeneca's Q4 Misses Profit Estimates, But Management Stays Upbeat 11:29 a.m. Feb. 13, 2015 - GuruFocus.com
FDA accepts Pfizer's NDA for abuse-deterrent opioid 11:22 a.m. Feb. 13, 2015 - Seeking Alpha
Ackman vs. Icahn: How Two Billionaires, Former Adversaries, Stack Up 11:14 a.m. Feb. 13, 2015 - TheStreet.com
Will Masimo Corp (MASI) Disappoint Q4 Earnings Estimates? - Analyst Blog 10:30 a.m. Feb. 13, 2015 - Zacks.com
Can Radius Health (RDUS) Surprise This Earnings Season? - Analyst Blog 10:06 a.m. Feb. 13, 2015 - Zacks.com
Actavis divests pharma outsourcing business to private equity firm 9:45 a.m. Feb. 13, 2015 - Seeking Alpha
Ironwood Pharmaceuticals Cuts Loss on Higher Revenues - Analyst Blog 9:22 a.m. Feb. 13, 2015 - Zacks.com
Actavis To Divest Pharmatect To TPG, No Terms Disclosed 7:33 a.m. Feb. 13, 2015 - benzinga.com
Allergan (AGN) Stock: Keep On Buying This Botox Baron 12:00 a.m. Feb. 13, 2015 - InvestorPlace.com
Don't Discount Bill Ackman 12:13 p.m. Feb. 11, 2015 - Seeking Alpha
3 Stocks Boosting The Drugs Industry Higher 12:10 p.m. Feb. 11, 2015 - TheStreet.com
Will Kite Pharma (KITE) Disappoint this Earnings Season? - Analyst Blog 10:40 a.m. Feb. 11, 2015 - Zacks.com
CVRs - The Good, The Bad And The Ugly 1:40 a.m. Feb. 11, 2015 - Seeking Alpha
Actavis to Divest U.S. Rights of Doryx to Mayne Pharma - Analyst Blog 3:41 p.m. Feb. 10, 2015 - Zacks.com
DaVita Healthcare (DVA): What's in Store for Q4 Earnings? - Analyst Blog 3:30 p.m. Feb. 10, 2015 - Zacks.com
Actavis Launches Generic Pulmicort RESPULES® 4:28 p.m. Feb. 13, 2015 - PR Newswire - PRF
Actavis to Divest Pharmatech to TPG 8:30 a.m. Feb. 13, 2015 - PR Newswire - PRF
World Intravenous (IV) Iron Drugs Industry 12:39 p.m. Feb. 10, 2015 - PR Newswire - PRF
Actavis to Divest Doryx® to Mayne Pharma 5:23 p.m. Feb. 9, 2015 - PR Newswire - PRF
Fresh Deals on W-Street: Special Research on Hospira, BT Group, Actavis, Ball, and Frontier 8:10 a.m. Feb. 6, 2015 - PR Newswire - PRF
Galena Biopharma Announces Orexo's Filing of a Patent Infringement Lawsuit Against Actavis Concerning Abstral(R) (fentanyl) Sublingual Tablets in the U.S. 7:05 a.m. Feb. 5, 2015 - GlobeNewswire
Actavis to Divest Rights to Branded Respiratory Portfolio in the U.S. and Canada to AstraZeneca 2:05 a.m. Feb. 5, 2015 - PR Newswire - PRF
Actavis Announces FDA Acceptance of sNDA to Expand TEFLARO® (ceftaroline fosamil) Labeling 8:00 a.m. Feb. 4, 2015 - PR Newswire - PRF
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - BusinessWire - BZX
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - PR Newswire - PRF
Actavis to Acquire Auden Mckenzie for 306M GBP 7:30 a.m. Jan. 26, 2015 - PR Newswire - PRF
Richter and Actavis Announce Positive Phase III Results for Cariprazine in the Prevention of Relapse in Patients with Schizophrenia 2:00 a.m. Jan. 20, 2015 - PR Newswire - PRF
Actavis Launches U.S. Generic Specialty Injectable Portfolio 8:00 a.m. Jan. 13, 2015 - PR Newswire - PRF
Equities Updates on Health Care Sector - Johnson and Johnson, VIVUS, Actavis, Covance, and Sequenom 8:35 a.m. Jan. 12, 2015 - PR Newswire - PRF
Actavis Announces Exceptional Preliminary Fourth Quarter 2014 Performance 8:30 a.m. Jan. 12, 2015 - PR Newswire - PRF
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis’ Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:02 a.m. Jan. 12, 2015 - BusinessWire - BZX
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
Actavis Confirms Appeals Court Grants Expedited Appeal of Ruling Requiring Continued Distribution of NAMENDA® IR 3:54 p.m. Jan. 6, 2015 - PR Newswire - PRF
Actavis and Gedeon Richter Announce FDA Receipt of NDA Resubmission for Cariprazine 2:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Timing is Crucial, Upside Analysis: Research Reports on Alder, Sky Solar, CNinsure, Raytheon, and Actavis 9:00 a.m. Dec. 29, 2014 - PR Newswire - PRF
AstraZeneca to buy Actavis respiratory-drug unit 3:20 a.m. Feb. 5, 2015 - MarketWatch.com
Allergan profit surges on higher sales 5:50 p.m. Feb. 4, 2015 - MarketWatch.com
Options remain limited for growth-stock speculators 3:16 p.m. Jan. 22, 2015 - The Trading Deck
These unloved stocks may beat the S&P 500 again in 2015 10:56 a.m. Jan. 20, 2015 - Brett Arends
10 hated stocks your portfolio will love 6:01 a.m. Jan. 20, 2015 - Brett Arends
Actavis expects profit to beat expectations 9:44 a.m. Jan. 12, 2015 - Michael Calia
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
10 stocks that can withstand a rocky 2015 12:31 p.m. Dec. 31, 2014 - The Trading Deck
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Here are the best S&P 500 stocks and sectors of 2014 1:52 p.m. Dec. 29, 2014 - Philip van Doorn
2014 was the year that all predictions were wrong 11:29 a.m. Dec. 26, 2014 - Marek Fuchs
GoPro, Adamas climb, Cal-Maine slides 10:06 a.m. Dec. 24, 2014 - MarketWatch
Adamas' stock soars after dementia treatment approval 8:24 a.m. Dec. 24, 2014 - Tomi Kilgore
Second 2% S&P 500 spike signals strong bull trend 11:23 a.m. Dec. 19, 2014 - Michael Ashbaugh
What a week: Botox haze, merger Monday and The Tanned One 9:19 a.m. Nov. 21, 2014 - Marek Fuchs
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Nov. 20, 2014 - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
S&P, Dow ring up records Tuesday 4:35 p.m. Nov. 18, 2014 - Barbara Kollmeyer
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Jim Cramer's Top Stock Picks: ACT PCLN CLX HAIN WWAV NVAX 6:00 a.m. Feb. 14, 2015 - TheStreet.com
How Alger’s Patrick Kelly Stays Ahead of the Game 2:15 a.m. Feb. 14, 2015 - Barrons.com
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:03 p.m. Feb. 13, 2015 - TheStreet.com
Salix, Top Drug Stocks Rally As Merger Mania Heats Up 5:08 p.m. Feb. 13, 2015 - Investors Business Daily
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More 4:00 p.m. Feb. 13, 2015 - Seeking Alpha
AstraZeneca's Q4 Misses Profit Estimates, But Management Stays Upbeat 11:29 a.m. Feb. 13, 2015 - GuruFocus.com
FDA accepts Pfizer's NDA for abuse-deterrent opioid 11:22 a.m. Feb. 13, 2015 - Seeking Alpha
Ackman vs. Icahn: How Two Billionaires, Former Adversaries, Stack Up 11:14 a.m. Feb. 13, 2015 - TheStreet.com
Will Masimo Corp (MASI) Disappoint Q4 Earnings Estimates? - Analyst Blog 10:30 a.m. Feb. 13, 2015 - Zacks.com
Can Radius Health (RDUS) Surprise This Earnings Season? - Analyst Blog 10:06 a.m. Feb. 13, 2015 - Zacks.com
Actavis divests pharma outsourcing business to private equity firm 9:45 a.m. Feb. 13, 2015 - Seeking Alpha
Ironwood Pharmaceuticals Cuts Loss on Higher Revenues - Analyst Blog 9:22 a.m. Feb. 13, 2015 - Zacks.com
Actavis To Divest Pharmatect To TPG, No Terms Disclosed 7:33 a.m. Feb. 13, 2015 - benzinga.com
Allergan (AGN) Stock: Keep On Buying This Botox Baron 12:00 a.m. Feb. 13, 2015 - InvestorPlace.com
Don't Discount Bill Ackman 12:13 p.m. Feb. 11, 2015 - Seeking Alpha
3 Stocks Boosting The Drugs Industry Higher 12:10 p.m. Feb. 11, 2015 - TheStreet.com
Will Kite Pharma (KITE) Disappoint this Earnings Season? - Analyst Blog 10:40 a.m. Feb. 11, 2015 - Zacks.com
CVRs - The Good, The Bad And The Ugly 1:40 a.m. Feb. 11, 2015 - Seeking Alpha
Actavis to Divest U.S. Rights of Doryx to Mayne Pharma - Analyst Blog 3:41 p.m. Feb. 10, 2015 - Zacks.com
DaVita Healthcare (DVA): What's in Store for Q4 Earnings? - Analyst Blog 3:30 p.m. Feb. 10, 2015 - Zacks.com
Actavis Launches Generic Pulmicort RESPULES® 4:28 p.m. Feb. 13, 2015 - PR Newswire - PRF
Actavis to Divest Pharmatech to TPG 8:30 a.m. Feb. 13, 2015 - PR Newswire - PRF
World Intravenous (IV) Iron Drugs Industry 12:39 p.m. Feb. 10, 2015 - PR Newswire - PRF
Actavis to Divest Doryx® to Mayne Pharma 5:23 p.m. Feb. 9, 2015 - PR Newswire - PRF
Fresh Deals on W-Street: Special Research on Hospira, BT Group, Actavis, Ball, and Frontier 8:10 a.m. Feb. 6, 2015 - PR Newswire - PRF
Galena Biopharma Announces Orexo's Filing of a Patent Infringement Lawsuit Against Actavis Concerning Abstral(R) (fentanyl) Sublingual Tablets in the U.S. 7:05 a.m. Feb. 5, 2015 - GlobeNewswire
Actavis to Divest Rights to Branded Respiratory Portfolio in the U.S. and Canada to AstraZeneca 2:05 a.m. Feb. 5, 2015 - PR Newswire - PRF
Actavis Announces FDA Acceptance of sNDA to Expand TEFLARO® (ceftaroline fosamil) Labeling 8:00 a.m. Feb. 4, 2015 - PR Newswire - PRF
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - BusinessWire - BZX
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - PR Newswire - PRF
Actavis to Acquire Auden Mckenzie for 306M GBP 7:30 a.m. Jan. 26, 2015 - PR Newswire - PRF
Richter and Actavis Announce Positive Phase III Results for Cariprazine in the Prevention of Relapse in Patients with Schizophrenia 2:00 a.m. Jan. 20, 2015 - PR Newswire - PRF
Actavis Launches U.S. Generic Specialty Injectable Portfolio 8:00 a.m. Jan. 13, 2015 - PR Newswire - PRF
Equities Updates on Health Care Sector - Johnson and Johnson, VIVUS, Actavis, Covance, and Sequenom 8:35 a.m. Jan. 12, 2015 - PR Newswire - PRF
Actavis Announces Exceptional Preliminary Fourth Quarter 2014 Performance 8:30 a.m. Jan. 12, 2015 - PR Newswire - PRF
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis’ Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:02 a.m. Jan. 12, 2015 - BusinessWire - BZX
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
Actavis Confirms Appeals Court Grants Expedited Appeal of Ruling Requiring Continued Distribution of NAMENDA® IR 3:54 p.m. Jan. 6, 2015 - PR Newswire - PRF
Actavis and Gedeon Richter Announce FDA Receipt of NDA Resubmission for Cariprazine 2:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Timing is Crucial, Upside Analysis: Research Reports on Alder, Sky Solar, CNinsure, Raytheon, and Actavis 9:00 a.m. Dec. 29, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼